Healthy Skepticism Library item: 4905
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: Journal Article
Anand G.
Why Genzyme can charge so much for Cerezyme.
Wall St J (East Ed) 2005 Nov 16; A15:
Keywords:
Biotechnology
Costs and Cost Analysis/economics
Gaucher Disease/drug therapy*
Glucosylceramidase/economics*
Glucosylceramidase/therapeutic use*
Humans
Industry/economics*
Insurance, Health, Reimbursement*
Orphan Drug Production/economics
Rare Diseases/drug therapy*
United States